INSIGHTS ON CLINICAL TRIAL REGULATORY ISSUES

• Paper COAs In 2026? It's Not "Cheaper," It's Riskier

  Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

• Which FIH Decisions Are Hardest To Reverse Later?

  Early oncology trial decisions can lock in risk, shape regulatory confidence, and limit flexibility. Knowing which choices are hardest to reverse protects optionality and credibility.

• Medical Device Clinical Trials: Key Considerations For Sponsors And CROs

  Medical device trials must align risk class, regulations, and study design. Strong oversight, data, and proactive safety planning support reliable evidence and market approval.

• A Guide To Medical Coding In Clinical Trials

  Medical coding transforms free-text clinical data into standardized terminology, enabling consistent analysis, safety monitoring, and regulatory review. Clear guidelines and quality control help reduce variability and protect data integrity across the entire clinical trial lifecycle.

• Staying Audit-Ready: Practical Compliance Insights For Clinical Research Sites

  3/26/2026

  Gain an auditor’s insight into common compliance gaps and learn practical ways to strengthen audit readiness in sIRB studies. 

• The Patient Experience Paradox: eCOA Strategy Overhaul

  3/25/2026

  European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.

• Implications Of Assessing Overall Survival In Oncology Studies

  3/25/2026

  New oncology standards mandate pre-specified survival analysis to catch long-term harm. Learn how to implement hazard ratio thresholds and the ICH E9(R1) framework for global compliance.

• The End Of The "PRO Tax": Top 10 Commercial PROs & Their Cost-Effective Alternatives

  3/25/2026

  Regulators now prioritize fit-for-purpose data over legacy instrument brand names. Modernizing your assessment strategy reduces licensing delays and improves trial startup speed and efficiency.

• 10 Clinical Research Practices That Feel Like Compliance (But Aren't)

  3/24/2026

  Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.

REGULATORY MULTIMEDIA

• Staying Audit-Ready: Practical Compliance Insights For Clinical Research Sites

  Gain an auditor’s insight into common compliance gaps and learn practical ways to strengthen audit readiness in sIRB studies. 

• European Clinical Supply Planning – Balancing Cost, Flexibility And Time

  See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.

• Trials Without Borders: New UK Clinical Trial Regulations

  The UK is undergoing its most significant overhaul of clinical trials regulations in decades, and U.S. sponsors need to take notice. In this episode of Trials Without Borders, brought to you by Clinical Leader and FlexPoint Bio, host Elena Sinclair and co-host Ross Jackson sit down with UK-based experts to unpack what's changing and where American biotechs most often stumble.

• Unlocking The Promise of Digital Health Technologies In Clinical Trials

  Discover the scientific, regulatory, and operational hurdles slowing digital health in clinical trials — and how design, guidance, and validation improvements are moving adoption ahead.

   

• Transform Clinical Data Management Through A Unified Workspace

  Discover how unified clinical data infrastructure replaces spreadsheets with AI-driven oversight, delivering traceable decisions and regulatory-ready documentation that accelerates timelines.

• AI-Powered Custom Listing Generator

  Explore how natural language queries enable instant clinical listings while maintaining oversight, as well as what becomes possible when teams reduce manual effort without sacrificing control.

• Behind The Submissions: Regulatory Experts Share Their Experiences

  From gap analyses and tailored strategies to leading pre-IND and pre-CTA meetings, we ensure you’re fully prepared — with cross-functional alignment, rehearsals, and submission-ready documentation.

• Delivering Value In Clinical Trial Services By Managing Complexity, Timelines

  Gain insights into managing global trial complexity, balancing accelerated timelines with compliance, using advanced technologies to improve efficiency, and leveraging partnerships to support seamless clinical operations.

• Plain Language Summaries A Necessity For Global Transparency

  As regulatory authorities and industry stakeholders increasingly prioritize accessible communication, PLS are becoming not only a best practice but, in many regions, an emerging requirement.

• Measuring Treatment Tolerability In Oncology: Expert Panel Discussion

  Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.